重性抑郁障碍的前瞻性生物标志物:系统综述与荟萃分析
该系统综述与荟萃分析检索截至2019年6月的文献,纳入75篇前瞻性研究,评估神经影像、免疫、激素等多类生物标志物对重性抑郁障碍发病或复发的预测价值。仅皮质醇显示预测效应(OR=1.294,p=0.024),但排除基线有临床诊断的研究后该效应消失,提示主要生物学理论缺乏前瞻性证据。
要点
- 仅皮质醇对MDD发病/复发有预测效应(OR=1.294,p=0.024),但对时间无预测。
- 脑体积与免疫标志物的荟萃分析均不显著。
- 排除基线有临床诊断的研究后,皮质醇预测效应消失,提示受疾病状态影响。
核心结论
- 主要生物学理论对抑郁发作与维持缺乏前瞻性证据,仅皮质醇为潜在预测因子但受疾病状态影响。
研究设计与样本
- 系统综述与荟萃分析,检索Pubmed、Embase和PsychInfo截至2019年6月,共纳入75篇前瞻性研究。
- 纳入标准为以MDD诊断为结局、生物标志物为预测因子、前瞻性设计,遵循PRISMA指南。
- 当三个或以上可比研究时采用随机效应模型进行荟萃分析。
主要发现
- 纳入的75篇前瞻性研究中,神经影像24篇、胃肠道因素1篇、免疫8篇、神经营养因子2篇、神经递质1篇、激素39篇、氧化应激1篇。
- 脑体积和免疫标志物的荟萃分析均不显著。
- 皮质醇显示对MDD发病/复发/再发的预测效应(N=19,OR=1.294,p=0.024),但对至MDD发病/复发/再发的时间无预测效应。
- 排除基线有临床诊断的参与者研究后,皮质醇的预测效应消失。
- 其他研究异质性过大无法比较。
关键数值与推荐
- 皮质醇对MDD发病/复发/再发的预测效应:N=19,OR=1.294,p=0.024。
- 脑体积和免疫标志物的荟萃分析无统计学显著性。
临床怎么用
- 目前尚无足够前瞻性证据支持将主要生物学标志物用于MDD发病或复发的临床预测。
- 皮质醇的预测效应受基线疾病状态影响,解读时需考虑临床状态。
- 需高质量前瞻性研究以区分MDD的病因与维持机制。
局限性
- 多数生物标志物类别研究数量少或异质性大,无法进行荟萃分析。
- 皮质醇的预测效应在排除基线有临床诊断的研究后消失,提示结果受疾病状态混杂。
- 检索截至2019年6月,未纳入此后发表的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leading biological hypotheses propose that biological changes may underlie major depressive disorder onset and relapse/recurrence. Here, we investigate if there is prospective evidence for biomarkers derived from leading theories. We focus on neuroimaging, gastrointestinal factors, immunology, neurotrophic factors, neurotransmitters, hormones, and oxidative stress. Searches were performed in Pubmed, Embase and PsychInfo for articles published up to 06/2019. References and citations of included articles were screened to identify additional articles. Inclusion criteria were having an MDD diagnosis as outcome, a biomarker as predictor, and prospective design search terms were formulated accordingly. PRISMA guidelines were applied. Meta-analyses were performed using a random effect model when three or more comparable studies were identified, using a random effect model. Our search resulted in 67,464 articles, of which 75 prospective articles were identified on: Neuroimaging (N = 24), Gastrointestinal factors (N = 1), Immunology (N = 8), Neurotrophic (N = 2), Neurotransmitters (N = 1), Hormones (N = 39), Oxidative stress (N = 1). Meta-analyses on brain volumes and immunology markers were not significant. Only cortisol (N = 19, OR = 1.294, p = 0.024) showed a predictive effect on onset/relapse/recurrence of MDD, but not on time until MDD onset/relapse/recurrence. However, this effect disappeared when studies including participants with a baseline clinical diagnosis were removed from the analyses. Other studies were too heterogeneous to compare. Thus, there is a lack of evidence for leading biological theories for onset and maintenance of depression. Only cortisol was identified as potential predictor for MDD, but results are influenced by the disease state. High-quality (prospective) studies on MDD are needed to disentangle the etiology and maintenance of MDD.
引用
- Kennis M, Gerritsen L, van Dalen M, et al. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry. 2019. PMID: 31745238. doi:10.1038/s41380-019-0585-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。